GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmaids Pharmaceuticals Ltd (BOM:524572) » Definitions » EPS (Basic)

Pharmaids Pharmaceuticals (BOM:524572) EPS (Basic) : ₹-3.16 (TTM As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Pharmaids Pharmaceuticals EPS (Basic)?

Pharmaids Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹-1.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-3.16.

Pharmaids Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2025 was ₹-1.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-3.16.

Pharmaids Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2025 was ₹-1.13. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -3.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Pharmaids Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 99.20% per year. The lowest was -175.00% per year. And the median was 55.30% per year.


Pharmaids Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Pharmaids Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaids Pharmaceuticals EPS (Basic) Chart

Pharmaids Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.14 -5.86 -3.56 -3.05

Pharmaids Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 -0.76 -0.73 -0.55 -1.12

Pharmaids Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pharmaids Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-107.766-0)/35.333
=-3.05

Pharmaids Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-39.388-0)/35.268
=-1.12

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-3.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaids Pharmaceuticals  (BOM:524572) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pharmaids Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Pharmaids Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaids Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
HMT Factory Road, Unit 201, Brigade Rubix, 20/14, Peenya Plantation, Bangalore, KA, IND, 560013
Pharmaids Pharmaceuticals Ltd is an India-based pharmaceutical company. It is mainly engaged in the business contract research and manufacturing services. The products are offered in the areas of hospital care products, skin care products, specialty chemicals, and others. It generates revenue from the sale of its products.

Pharmaids Pharmaceuticals Headlines

No Headlines